480 related articles for article (PubMed ID: 29446766)
1. Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature.
Schwarze K; Buchanan J; Taylor JC; Wordsworth S
Genet Med; 2018 Oct; 20(10):1122-1130. PubMed ID: 29446766
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness of Whole-Genome vs Whole-Exome Sequencing Among Children With Suspected Genetic Disorders.
Nurchis MC; Radio FC; Salmasi L; Heidar Alizadeh A; Raspolini GM; Altamura G; Tartaglia M; Dallapiccola B; Pizzo E; Gianino MM; Damiani G
JAMA Netw Open; 2024 Jan; 7(1):e2353514. PubMed ID: 38277144
[TBL] [Abstract][Full Text] [Related]
3. Whole-genome sequencing offers additional but limited clinical utility compared with reanalysis of whole-exome sequencing.
Alfares A; Aloraini T; Subaie LA; Alissa A; Qudsi AA; Alahmad A; Mutairi FA; Alswaid A; Alothaim A; Eyaid W; Albalwi M; Alturki S; Alfadhel M
Genet Med; 2018 Nov; 20(11):1328-1333. PubMed ID: 29565419
[TBL] [Abstract][Full Text] [Related]
4. Clinical Application of Genome and Exome Sequencing as a Diagnostic Tool for Pediatric Patients: a Scoping Review of the Literature.
Smith HS; Swint JM; Lalani SR; Yamal JM; de Oliveira Otto MC; Castellanos S; Taylor A; Lee BH; Russell HV
Genet Med; 2019 Jan; 21(1):3-16. PubMed ID: 29760485
[TBL] [Abstract][Full Text] [Related]
5. Incremental net benefit of whole genome sequencing for newborns and children with suspected genetic disorders: Systematic review and meta-analysis of cost-effectiveness evidence.
Nurchis MC; Riccardi MT; Radio FC; Chillemi G; Bertini ES; Tartaglia M; Cicchetti A; Dallapiccola B; Damiani G
Health Policy; 2022 Apr; 126(4):337-345. PubMed ID: 35317923
[TBL] [Abstract][Full Text] [Related]
6. Systematic dissection of biases in whole-exome and whole-genome sequencing reveals major determinants of coding sequence coverage.
Barbitoff YA; Polev DE; Glotov AS; Serebryakova EA; Shcherbakova IV; Kiselev AM; Kostareva AA; Glotov OS; Predeus AV
Sci Rep; 2020 Feb; 10(1):2057. PubMed ID: 32029882
[TBL] [Abstract][Full Text] [Related]
7. Using the Sankey diagram to visualize article features on the topics of whole-exome sequencing (WES) and whole-genome sequencing (WGS) since 2012: Bibliometric analysis.
Li MJ; Chien TW; Liao KW; Lai FJ
Medicine (Baltimore); 2022 Sep; 101(38):e30682. PubMed ID: 36197161
[TBL] [Abstract][Full Text] [Related]
8. Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis.
Ewans LJ; Minoche AE; Schofield D; Shrestha R; Puttick C; Zhu Y; Drew A; Gayevskiy V; Elakis G; Walsh C; Adès LC; Colley A; Ellaway C; Evans CA; Freckmann ML; Goodwin L; Hackett A; Kamien B; Kirk EP; Lipke M; Mowat D; Palmer E; Rajagopalan S; Ronan A; Sachdev R; Stevenson W; Turner A; Wilson M; Worgan L; Morel-Kopp MC; Field M; Buckley MF; Cowley MJ; Dinger ME; Roscioli T
Eur J Hum Genet; 2022 Oct; 30(10):1121-1131. PubMed ID: 35970915
[TBL] [Abstract][Full Text] [Related]
9. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples.
Bailey MH; Meyerson WU; Dursi LJ; Wang LB; Dong G; Liang WW; Weerasinghe A; Li S; Li Y; Kelso S; ; ; Saksena G; Ellrott K; Wendl MC; Wheeler DA; Getz G; Simpson JT; Gerstein MB; Ding L;
Nat Commun; 2020 Sep; 11(1):4748. PubMed ID: 32958763
[TBL] [Abstract][Full Text] [Related]
10. Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders.
Ewans LJ; Schofield D; Shrestha R; Zhu Y; Gayevskiy V; Ying K; Walsh C; Lee E; Kirk EP; Colley A; Ellaway C; Turner A; Mowat D; Worgan L; Freckmann ML; Lipke M; Sachdev R; Miller D; Field M; Dinger ME; Buckley MF; Cowley MJ; Roscioli T
Genet Med; 2018 Dec; 20(12):1564-1574. PubMed ID: 29595814
[TBL] [Abstract][Full Text] [Related]
11. Validated WGS and WES protocols proved saliva-derived gDNA as an equivalent to blood-derived gDNA for clinical and population genomic analyses.
Kvapilova K; Misenko P; Radvanszky J; Brzon O; Budis J; Gazdarica J; Pos O; Korabecna M; Kasny M; Szemes T; Kvapil P; Paces J; Kozmik Z
BMC Genomics; 2024 Feb; 25(1):187. PubMed ID: 38365587
[TBL] [Abstract][Full Text] [Related]
12. A microcosting and cost-consequence analysis of clinical genomic testing strategies in autism spectrum disorder.
Tsiplova K; Zur RM; Marshall CR; Stavropoulos DJ; Pereira SL; Merico D; Young EJ; Sung WWL; Scherer SW; Ungar WJ
Genet Med; 2017 Nov; 19(11):1268-1275. PubMed ID: 28471434
[TBL] [Abstract][Full Text] [Related]
13. The current benefit of genome sequencing compared to exome sequencing in patients with developmental or epileptic encephalopathies.
Grether A; Ivanovski I; Russo M; Begemann A; Steindl K; Abela L; Papik M; Zweier M; Oneda B; Joset P; Rauch A
Mol Genet Genomic Med; 2023 May; 11(5):e2148. PubMed ID: 36785910
[TBL] [Abstract][Full Text] [Related]
14. Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness.
Stark Z; Schofield D; Martyn M; Rynehart L; Shrestha R; Alam K; Lunke S; Tan TY; Gaff CL; White SM
Genet Med; 2019 Jan; 21(1):173-180. PubMed ID: 29765138
[TBL] [Abstract][Full Text] [Related]
15. Whole exome sequencing in neurogenetic odysseys: An effective, cost- and time-saving diagnostic approach.
Córdoba M; Rodriguez-Quiroga SA; Vega PA; Salinas V; Perez-Maturo J; Amartino H; Vásquez-Dusefante C; Medina N; González-Morón D; Kauffman MA
PLoS One; 2018; 13(2):e0191228. PubMed ID: 29389947
[TBL] [Abstract][Full Text] [Related]
16. Organizational Aspects of the Implementation and Use of Whole Genome Sequencing and Whole Exome Sequencing in the Pediatric Population in Italy: Results of a Survey.
Nurchis MC; Raspolini GM; Heidar Alizadeh A; Altamura G; Radio FC; Tartaglia M; Dallapiccola B; Damiani G
J Pers Med; 2023 May; 13(6):. PubMed ID: 37373888
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders.
Soden SE; Saunders CJ; Willig LK; Farrow EG; Smith LD; Petrikin JE; LePichon JB; Miller NA; Thiffault I; Dinwiddie DL; Twist G; Noll A; Heese BA; Zellmer L; Atherton AM; Abdelmoity AT; Safina N; Nyp SS; Zuccarelli B; Larson IA; Modrcin A; Herd S; Creed M; Ye Z; Yuan X; Brodsky RA; Kingsmore SF
Sci Transl Med; 2014 Dec; 6(265):265ra168. PubMed ID: 25473036
[TBL] [Abstract][Full Text] [Related]
18. [Whole exome sequencing and whole genome sequencing in undiagnosed disease: of value for certain patient populations].
Linthorst GE; Hollak CEM
Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31120221
[TBL] [Abstract][Full Text] [Related]
19. Whole genome sequencing diagnostic yield for paediatric patients with suspected genetic disorders: systematic review, meta-analysis, and GRADE assessment.
Nurchis MC; Altamura G; Riccardi MT; Radio FC; Chillemi G; Bertini ES; Garlasco J; Tartaglia M; Dallapiccola B; Damiani G
Arch Public Health; 2023 May; 81(1):93. PubMed ID: 37231492
[TBL] [Abstract][Full Text] [Related]
20. Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies.
Mackley MP; Fletcher B; Parker M; Watkins H; Ormondroyd E
Genet Med; 2017 Mar; 19(3):283-293. PubMed ID: 27584911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]